10:31 ETComplement 3 Glomerulopathy Market Set for Transformation: 4 Emerging Therapies Leading the Next Growth Phase | DelveInsightprnewswire·Jul 16 at 09:31 AMKPRX0.00%ARWR+1.89%
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium | KPRX Stock NewsStockTitan·Jul 1 at 10:00 PMKPRX0.00%
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model | KPRX Stock NewsStockTitan·Jun 17 at 10:00 PMKPRX0.00%
Kiora Pharmaceuticals Inc 1Q 2026: Revenue ($2.4M), Net income ($2.42M), EPS ($0.58) — 10-Q SummaryTradingView·May 8 at 06:11 AMKPRX0.00%FBT+0.78%
Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock NewsStockTitan·May 7 at 10:05 PMKPRX0.00%IBB+1.00%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·Apr 13 at 04:05 PMSANA+3.96%KPRX0.00%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Apr 8 at 12:05 PMIBB+1.00%ARKG0.00%
U.S. stock market midday update: Kiora Pharmaceuticals financing news sparks market enthusiasm, stock price surges 19.76%!Price Alert·Apr 8 at 10:28 AMKPRX0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Apr 7 at 07:05 AMPFSA-39.77%KPRX0.00%
Kiora Pharmaceuticals shares are trading higher after the company announced it will sell up to 438,471 shares in a private placement.benzinga_article·Apr 7 at 07:01 AMKPRX0.00%LABU+2.61%
Kiora Pharmaceuticals Announces $5 Million Private Placement FinancingTip Ranks·Apr 7 at 06:30 AMFBT+0.78%LABU+2.61%
